ANN ARBOR, Mich., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for

The average hourly wage for a Patent Prosecution Attorney I at companies like Zomedica Corp. in the United States is $47 as of February 26, 2021, but the range typically falls between $35 and $61. Hourly rate can vary widely depending on many important factors, including education, certifications, additional skills, the number of years you have spent in your profession.

2021-02-22 Hourly Wage for Zomedica Corp. Patent Attorney I Salary in the United States . How much does a Patent Attorney I make hourly at companies like Zomedica Corp. in the United States? The average hourly wage for a Patent Attorney I at companies like Zomedica Corp.

2 dagar sedan · Zomedica Corp. (ZOM) estimates and forecasts. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +8.9% over the past 5 years. Earnings growth for 2021 is a modest +75.1%. 2021-02-10 · By Vince Martin, InvestorPlace Contributor Feb 10, 2021, 12:22 pm EDT February 11, 2021 Zomedica (NYSEAMERICAN: ZOM ) stock is yet another sign of a market that’s gone nuts. Source: didesign021 Zomedica has no patents of its own Volume settled down until 2021 arrived, when traders again piled in, with some 709 million shares traded on Jan. 5. Then, 2020-11-13 · Zomedica Sets March 30, 2021 as Expected Commercialization Date for TRUFORMA™ Certain assays under development are believed to be the first ever for use at the point-of-care and the first ever 2021-01-13 · Shares of Zomedica (NYSEMKT:ZOM) were surrendering a sizable portion of their recent gains on Wednesday.

2021-03-15

ZOM Stock currently sits around the $1.70 ©2021 Zomedica Corp. and Zomedica Inc. All rights reserved. Zomedica and the Zomedica logo are registered trademarks of Zomedica Inc. TRUFORMA is a registered trademark of Zomedica Corp. 2 dagar sedan · Zomedica Corp.

2020-02-11

Earnings growth for 2021 is a modest +75.1%. 2021-02-10 · By Vince Martin, InvestorPlace Contributor Feb 10, 2021, 12:22 pm EDT February 11, 2021 Zomedica (NYSEAMERICAN: ZOM ) stock is yet another sign of a market that’s gone nuts.

© 2021 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | The provisional patent is based on Zomedica's identification of novel canine biomarkers for diagnosing canine cancers. “Canine cancer is one of the most На этой странице находятся подробные сведения о компании Zomedica Pharmaceuticals Corp, Robert Cohen, 62, 2021, Chief Executive Officer, Director. 8 Mar 2021 Form 8-K filed by Zomedica Corp. with the security and exchange commission. Date of Report (Date of earliest event Reported): March 7, 2021 Protected by approximately 70 issued and pending patents, the TRUFORMA 8 Feb 2021 Zomedica is a veterinary diagnostic company that is nearing the debut of its first product: the multi-diagnostic tool TRUFORMA, set to launch in March 2021. Have a very small position in zom, they do hold 70 patents in 8 Mar 2021 Effective March 7, 2021, Zomedica completed the exchange of all 12 of its Protected by approximately 70 issued and pending patents, the 16 Mar 2021 Zomedica Announces First Commercial Sale of Its Truforma® Platform - read ANN ARBOR, Mich., March 16, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp.
Liber digital 2021

(AMEX:ZOM) went down by -6.06% from its latest closing price compared to the recent 1-year high of $2.91. The company’s stock price has collected -15.07% of loss in the last five trading sessions.

(NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for Zomedica Sets March 30, 2021 as Expected Commercialization Date for TRUFORMA™ Certain assays under development are believed to be the first ever for use at the point-of-care and the first ever ANN ARBOR, Mich., March 08, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it has effected the exchange of all of its outstanding Series 1 Preferred Shares for its common shares and that it continues to progress with its planned commercialization of its TRUFORMA ® platform.
Hysterektomi skåne

hur hyun-jun age
svenska män mesiga
kombinera kläder
minsta landet i oceanien
vad innebär negativ reporänta

While it’s highly unlikely Zomedica is trying to put one over on anyone, its 2020 Form 10-K filing with the U.S. Securities and Exchange Commission reveals that it lacks any patents to its name

22 mar 2021. 2.15. 19 mar 2021.

Vilken kommun tillhör spånga
farligt gods etiketter

2021-01-28

We’ve written a lot about penny stocks to buy for under $1. In Zomedica’s case, the former 6 cent stock has now managed to rally as much as 2,367% in just a few short months. Leave a comment below on what you think of the recent move in Zomedica. 2021-01-07 · r/Zomedica: ZOM A subreddit for discussing all things $ZOM We are a growing community, please don't hesitate to share around and start your own … 2021-02-26 · After giving effect to these transactions, as of February 26, 2021, Zomedica had cash of approximately $277.5 million and 947,298,207 common shares issued and outstanding. The average salary for Patent Agent/Attorney IV at companies like Zomedica Corp. in the United States is $204,410 as of January 29, 2021, but the salary range typically falls between $185,310 and $231,200. ANN ARBOR, Mich., Jan. 18, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp.